Radiation Therapy for Locally Advanced Esophageal Cancer
- PMID: 28279468
- DOI: 10.1016/j.soc.2016.10.006
Radiation Therapy for Locally Advanced Esophageal Cancer
Abstract
The treatment of locally advanced esophageal cancer is controversial. For patients who are candidates for surgical resection, multiple prospective clinical trials have demonstrated the advantages of neoadjuvant chemoradiation. For patients who are medically inoperable, definitive chemoradiation is an alternative approach with survival rates comparable to trimodality therapy. Although trials of dose escalation are ongoing, the standard radiation dose remains 50.4 Gy. Modern radiotherapy techniques such as image-guided radiation therapy with motion management and intensity-modulated radiation therapy are strongly encouraged with a planning objective to maximize conformity to the intended target volume while reducing dose delivered to uninvolved normal tissues.
Keywords: Chemotherapy; Dose-escalation; Esophageal cancer; IMRT; Radiation.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study.Br J Radiol. 2015;88(1055):20150385. doi: 10.1259/bjr.20150385. Epub 2015 Sep 21. Br J Radiol. 2015. PMID: 26388108 Free PMC article. Clinical Trial.
-
Feasibility of intensity-modulated radiotherapy for esophageal cancer in definite chemoradiotherapy.J Chin Med Assoc. 2016 Jul;79(7):375-81. doi: 10.1016/j.jcma.2016.01.013. Epub 2016 Apr 4. J Chin Med Assoc. 2016. PMID: 27056108
-
Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation.Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):755-65. doi: 10.1016/j.ijrobp.2015.12.003. Epub 2015 Dec 11. Int J Radiat Oncol Biol Phys. 2016. PMID: 26972648 Free PMC article.
-
Radiation techniques for esophageal cancer.Chin Clin Oncol. 2017 Oct;6(5):45. doi: 10.21037/cco.2017.06.33. Chin Clin Oncol. 2017. PMID: 29129085 Review.
-
Optimal Use of Combined Modality Therapy in the Treatment of Esophageal Cancer.Surg Oncol Clin N Am. 2017 Jul;26(3):405-429. doi: 10.1016/j.soc.2017.01.009. Epub 2017 May 11. Surg Oncol Clin N Am. 2017. PMID: 28576180 Review.
Cited by
-
Efficacy and Safety of Simultaneous Integrated Boost Intensity-Modulation Radiation Therapy Combined with Systematic and Standardized Management for Esophageal Cancer.Front Surg. 2022 May 23;9:905678. doi: 10.3389/fsurg.2022.905678. eCollection 2022. Front Surg. 2022. PMID: 35677748 Free PMC article.
-
CDK4/6 inhibitor enhances the radiosensitization of esophageal squamous cell carcinoma (ESCC) by activating autophagy signaling via the suppression of mTOR.Am J Transl Res. 2022 Mar 15;14(3):1616-1627. eCollection 2022. Am J Transl Res. 2022. PMID: 35422963 Free PMC article.
-
Survival benefit of radiotherapy in metastatic esophageal cancer: a population-based study.Transl Cancer Res. 2019 Aug;8(4):1074-1085. doi: 10.21037/tcr.2019.06.15. Transl Cancer Res. 2019. PMID: 35116850 Free PMC article.
-
Optimization of Minimum Segment Width Parameter in the Intensity-Modulated Radiotherapy Plan for Esophageal Cancer.Int J Gen Med. 2021 Dec 16;14:9913-9921. doi: 10.2147/IJGM.S336269. eCollection 2021. Int J Gen Med. 2021. PMID: 34938110 Free PMC article.
-
Induction chemotherapy with albumin-bound paclitaxel plus lobaplatin followed by concurrent radiochemotherapy for locally advanced esophageal cancer.World J Gastrointest Oncol. 2021 Nov 15;13(11):1781-1790. doi: 10.4251/wjgo.v13.i11.1781. World J Gastrointest Oncol. 2021. PMID: 34853650 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
